Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-50505

Hofer, S; Elandt, K; Greil, R; Hottinger, A F; Huber, U; Lemke, D; Marosi, C; Ochsenbein, A; Pichler, J; Roelcke, U; Weder, P; Zander, T; Wick, W; Weller, M (2011). Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials. Acta Oncologica, 50(5):630-635.

[img]Published Version
PDF - Registered users only
89Kb

Abstract

Our data reveal valuable palliation with preservation of KPS and an option for steroid withdrawal in patients treated with BEV, supporting the role of this therapy in late-stage disease.

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
DDC:610 Medicine & health
Language:English
Date:2011
Deposited On:14 Nov 2011 14:37
Last Modified:22 Jan 2014 07:23
Publisher:Taylor & Francis
ISSN:0284-186X
Publisher DOI:10.3109/0284186X.2011.572913
PubMed ID:21495907
Citations:Web of Science®. Times Cited: 19
Google Scholar™

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page